Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)
Completed · Phase 3 · Has a placebo group
Conditions studied: HIV-1 Infection
In brief
The primary objective of this study is to evaluate the noninferiority of switching to emtricitabine/rilpivirine /tenofovir alafenamide (FTC/RPV/TAF) fixed-dose combination (FDC) as compared to continuing FTC/RPV/tenofovir disoproxil fumarate (TDF) FDC (FTC/RPV/TDF) in virologically suppressed HIV-1 infected participants.
Key facts
- Study ID
- NCT02345252
- Run by
- Gilead Sciences
- People needed
- 632
- Starts
- 2015-01-26
- Expected to finish
- 2019-01-09
- Last updated by the study team
- 2020-01-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Spectrum Medical Group — Phoenix, Arizona, United States
- AHF Research Center — Beverly Hills, California, United States
- Pacific Oaks Medical Group — Beverly Hills, California, United States
- Long Beach Education and Research Consultants — Long Beach, California, United States
- Kaiser Permanente — Los Angeles, California, United States
- Southern California Men's Medical Group — Los Angeles, California, United States
- Tarrant County ID Associates — Los Angeles, California, United States
- Alameda County Medical Center — Oakland, California, United States
- Desert Medical Group Inc., dba Desert Oasis Healthcare Medical Group — Palm Springs, California, United States
- Kaiser Permanente — Sacramento, California, United States
- University of California-UC Davis — Sacramento, California, United States
- La Playa Medical Group and Clinical Research — San Diego, California, United States
- Kaiser Permanente — San Francisco, California, United States
- Optimus Medical — San Francisco, California, United States
- Kaiser Permanente — San Leandro, California, United States
- Los Angeles BioMedical Institute at Harbor-UCLA Medical Center — Torrance, California, United States
- University of Colorado — Aurora, Colorado, United States
- Apex Research Institute — Denver, Colorado, United States
- Yale University School of Medicine — New Haven, Connecticut, United States
- World Health Clinicians' CIRCLE CARE Center — Norwalk, Connecticut, United States
- Capital Medical Associates, P.C. — Washington D.C., District of Columbia, United States
- Dupont Circle Physicians Group — Washington D.C., District of Columbia, United States
- Medical Faculty Associates — Washington D.C., District of Columbia, United States
- Whitman Walker Clinic — Washington D.C., District of Columbia, United States
- The University of Alabama at Birmingham (UAB) — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.